Experiment 990185

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationLAU,ME: HANSEN,HH: NISSEN,NI: PEDERSEN,H:. (1979). PHASE I TRIAL OF A NEW FORM OF AN ORAL ADMINISTRATION OF VP-16-213.. 63()
Amount utilized
Compound isolated
DiseasePHASE I CLINICAL TRIAL IN 26 PATIENTS WITH LUNG OR BREAST CANCER OR MALIGNANT MELANOMA MORE THAN 50% REGRESSION OF TUMORS WAS SEEN IN 3/26 PATIENTS DRUG WELL TOLERATED
Dose amount100.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES